title: Adult thymus transplantation with allogeneic intra-bone marrow-bone marrow transplantation from same donor induces high thymopoiesis, mild graft-versus-host reaction and strong graft-versus-tumour effects.
abstract: Although allogeneic bone marrow transplantation (BMT) plus donor lymphocyte infusion (DLI) is performed for solid tumours to enhance graft-versus-tumour (GVT) effects, a graft-versus-host reaction (GVHR) is also elicited. We carried out intra-bone marrow-bone marrow transplantation (IBM-BMT) plus adult thymus transplantation (ATT) from the same donor to supply alloreactive T cells continually. Normal mice treated with IBM-BMT + ATT survived for a long time with high donor-derived thymopoiesis and mild GVHR. The percentage of CD4(+) FoxP3(+) regulatory T cells in the spleen of the mice treated with IBM-BMT + ATT was lower than in normal B6 mice or mice treated with IBM-BMT alone, but higher than in mice treated with IBM-BMT + DLI; the mice treated with IBM-BMT + DLI showed severe GVHR. In tumour-bearing mice, tumour growth was more strongly inhibited by IBM-BMT + ATT than by IBM-BMT alone. Mice treated with IBM-BMT + a high dose of DLI also showed tumour regression comparable to that of mice treated with IBM-BMT + ATT but died early of GVHD. By contrast, mice treated with IBM-BMT + a low dose of DLI showed longer survival but less tumour regression than the mice treated with IBM-BMT + ATT. Histologically, significant numbers of CD8(+) T cells were found to have infiltrated the tumour in the mice treated with IBM-BMT + ATT. The number of terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-labelling (TUNEL)-positive apoptotic tumour cells also significantly increased in the mice treated with IBM-BMT + ATT. Allogeneic IBM-BMT + ATT thus can induce high thymopoiesis, preserving strong GVT effects without severe GVHR.
authors.affiliation: First Department of Pathology, Kansai Medical University, Moriguchi, Osaka, Japan.
authors.forename: Takashi
authors.initials: T
authors.lastname: Miyake
authors.forename: Naoki
authors.initials: N
authors.lastname: Hosaka
authors.forename: Wenhao
authors.initials: W
authors.lastname: Cui
authors.forename: Teruhisa
authors.initials: T
authors.lastname: Nishida
authors.forename: Takashi
authors.initials: T
authors.lastname: Takaki
authors.forename: Muneo
authors.initials: M
authors.lastname: Inaba
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Kamiyama
authors.forename: Susumu
authors.initials: S
authors.lastname: Ikehara
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000276:immunology; D001835:Body Weight; D016026:Bone Marrow Transplantation / Q000276:immunology*; D016207:Cytokines / Q000096:biosynthesis; D005260:Female; D006087:Graft vs Host Reaction / Q000276:immunology; D020350:Graft vs Tumor Effect / Q000276:immunology*; D018655:Lymphocyte Count; D007959:Lymphocyte Culture Test, Mixed; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation; D012513:Sarcoma, Experimental / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D013601:T-Lymphocytes / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D013950:Thymus Gland / Q000276:immunology / Q000502:physiology / Q000637:transplantation*; D018183:Transplantation Chimera / Q000276:immunology
chemical_list: D016207:Cytokines
references.citation: AIDS Res Hum Retroviruses. 2000 Mar 20;16(5):403-13
references.pmid: 10772526
references.citation: Curr Opin Immunol. 1999 Oct;11(5):509-15
references.pmid: 10508701
references.citation: Am J Surg Pathol. 2002 Aug;26(8):1078-82
references.pmid: 12170097
references.citation: Blood. 2004 Oct 1;104(7):2187-93
references.pmid: 15172973
references.citation: Nat Med. 2003 Sep;9(9):1117-8
references.pmid: 12949524
references.citation: J Exp Med. 2002 Aug 5;196(3):389-99
references.pmid: 12163567
references.citation: N Engl J Med. 1999 Oct 14;341(16):1180-9
references.pmid: 10523153
references.citation: Cytokine. 2005 Dec 21;32(6):255-62
references.pmid: 16368244
references.citation: Blood. 1995 Sep 1;86(5):2041-50
references.pmid: 7655033
references.citation: J Hematother Stem Cell Res. 2002 Apr;11(2):377-87
references.pmid: 11983109
references.citation: Bone Marrow Transplant. 2008 Apr;41(7):659-66
references.pmid: 18176618
references.citation: Semin Hematol. 2006 Jan;43(1):62-9
references.pmid: 16412790
references.citation: Exp Hematol. 2006 Sep;34(9):1271-7
references.pmid: 16939820
references.citation: Eur J Immunol. 1993 Apr;23(4):922-7
references.pmid: 8458378
references.citation: Nat Med. 2003 Sep;9(9):1144-50
references.pmid: 12925844
references.citation: Clin Exp Immunol. 2007 Mar;147(3):555-63
references.pmid: 17302907
references.citation: Immunol Rev. 2006 Aug;212:8-27
references.pmid: 16903903
references.citation: Transplantation. 2008 Apr 27;85(8):1151-8
references.pmid: 18431236
references.citation: Blood. 1997 Oct 15;90(8):3204-13
references.pmid: 9376604
references.citation: J Clin Invest. 1998 Jul 1;102(1):115-23
references.pmid: 9649564
references.citation: N Engl J Med. 1996 Feb 1;334(5):281-5
references.pmid: 8532022
references.citation: Blood. 2002 May 15;99(10):3838-43
references.pmid: 11986244
references.citation: Int J Immunopharmacol. 2000 Apr;22(4):261-73
references.pmid: 10689100
references.citation: Nat Immunol. 2006 Jul;7(7):709-14
references.pmid: 16785889
references.citation: Blood. 2000 Mar 1;95(5):1862-8
references.pmid: 10688849
references.citation: Exp Hematol. 2003 Dec;31(12):1142-6
references.pmid: 14662319
references.citation: Stem Cells. 2006 Feb;24(2):399-405
references.pmid: 16109754
references.citation: Nat Rev Immunol. 2004 Nov;4(11):856-67
references.pmid: 15516965
references.citation: Stem Cells. 2001;19(1):46-58
references.pmid: 11209090
references.citation: World J Surg. 2000 Jul;24(7):815-8
references.pmid: 10833248
references.citation: Bone Marrow Transplant. 2005 Sep;36(5):437-41
references.pmid: 15980879
references.citation: Lancet. 2004 May 1;363(9419):1439-41
references.pmid: 15121408
references.citation: Bone Marrow Transplant. 2008 Mar;41(6):537-45
references.pmid: 18084340
references.citation: Acta Haematol. 2000;103(1):19-25
references.pmid: 10705155
references.citation: Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8558-62
references.pmid: 8710909
references.citation: Blood. 1997 Jan 1;89(1):49-54
references.pmid: 8978276
references.citation: Mol Immunol. 2002 Mar;38(11):841-8
references.pmid: 11922942
references.citation: J Pediatr Hematol Oncol. 2007 Jan;29(1):57-9
references.pmid: 17230068
references.citation: Am J Hematol. 2002 Sep;71(1):41-4
references.pmid: 12221673
references.citation: Pediatr Int. 2007 Dec;49(6):795-800
references.pmid: 18045274
references.citation: Stem Cells. 2004;22(2):125-34
references.pmid: 14990852
references.citation: Stem Cells. 2005 Mar;23(3):365-70
references.pmid: 15749931
references.citation: J Clin Invest. 2003 Dec;112(11):1688-96
references.pmid: 14660744
references.citation: Hum Pathol. 2002 May;33(5):561-4
references.pmid: 12094384
references.citation: Blood. 2001 May 15;97(10):3292-9
references.pmid: 11342461
references.citation: Cell Res. 2007 Jan;17(1):50-5
references.pmid: 17146450
references.citation: Biol Blood Marrow Transplant. 1997 Apr;3(1):1-10
references.pmid: 9209735